Tristram Dan Bahnson, MD

Professor of Medicine
Campus mail 7623 Hosp North, Durham, NC 27710
Phone (919) 681-5441

Education and Training

  • Fellow in Cardiology, Medicine, University of California at San Diego, 1989 - 1994
  • Medical Resident, Medicine, University of California at Davis, 1984 - 1986
  • M.D., University of California, San Francisco, School of Medicine, 1984

Grants

Publications

Palmer, SM, Bahnson, T, and Davis, RD. "Atrial fibrillation, atrial flutter, or both after pulmonary transplantation [8]." Chest 127, no. 4 (2005): 1462--.

Full Text

Bahnson, TD, and Grant, AO. "To be or not to be in normal sinus rhythm: what do we really know?." Ann Intern Med 141, no. 9 (November 2, 2004): 727-729.

PMID
15520431
Scholars@Duke

Hranitzky, PM, Contrafatto, I, Kim, R, Ashar, MS, and Bahnson, TD. "MRI identifies significant variability in the anatomic relationship between the esophagus and left atrium in patients undergoing catheter ablation for atrial fibrillation." October 26, 2004.

Scholars@Duke

Nielsen, TD, Bahnson, T, Davis, RD, and Palmer, SM. "Atrial fibrillation after pulmonary transplant." Chest 126, no. 2 (August 2004): 496-500.

PMID
15302736
Full Text

Prystowsky, EN, Niazi, I, Curtis, AB, Wilber, DJ, Bahnson, T, Ellenbogen, K, Dhala, A, Bloomfield, DM, Gold, M, Kadish, A, Fogel, RI, Gonzalez, MD, Belardinelli, L, Shreeniwas, R, and Wolff, AA. "Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510), a novel A1-adenosine receptor agonist." J Am Coll Cardiol 42, no. 6 (September 17, 2003): 1098-1102.

PMID
13678937
Scholars@Duke

Campbell, KR, Whitehill, JM, Hesselson, A, Gallagher, P, and Bahnson, TD. "Dual-site or bi-atrial pacing does not enhance atrial activation as compared to pacing from novel single right atrial sites in humans." March 6, 2002.

Scholars@Duke

Reynolds, MR, Josephson, ME, Friedman, PA, Hadjis, T, Lemery, R, Bahnson, TD, Cannom, DS, and Zimetbaum, P. "Predictors of warfarin use in atrial fibrillation: Insights from the FRACTAL Registry." March 6, 2002.

Scholars@Duke

Niazi, I, Bahnson, TD, Lanzerotti, C, McPike, J, Kiemen, J, Kappel, D, Belardinelli, L, Cheng, J, Shreeniwas, R, and Wolff, AA. "Termination of supraventricular tachycardia with CVT-510, a selective A1 adenosine receptor agonist, is associated with fewer arrhythmias than adenosine." October 23, 2001.

Scholars@Duke

Prystowsky, E, Niazi, I, Curtis, AB, Dhalla, A, Bahnson, TD, Bloomfield, D, Gold, MR, Kadish, AH, Belardinelli, L, Shreeniwas, R, and Wolff, AA. "CVT-510, a novel selective A(1)-adenosine receptor agonist, terminates supraventricular tachycardia." October 31, 2000.

Scholars@Duke

Hesselson, AB, Gallagher, P, Al-Khatib, SM, Vergara, I, Bahnson, TD, and Wharton, JM. "Effect of age and structural heart disease on the number and distribution of focal initiators for atrial fibrillation." CIRCULATION 102, no. 18 (October 31, 2000): 444-444.

Scholars@Duke

Pages